-
Je něco špatně v tomto záznamu ?
J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial)
P. Zonča, T. Malý, P. Ihnát, M. Peteja, O. Kraft, K. Kuca,
Jazyk angličtina Země Nový Zéland
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008
ProQuest Central
od 2015-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Taylor & Francis Open Access
od 2008-12-01
Health & Medicine (ProQuest)
od 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
PubMed
28031718
DOI
10.2147/ott.s99628
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
PURPOSE: The aim of this study was to evaluate the quality of life and functional emptying of J-pouch versus Roux-en-Y reconstruction after total gastrectomy for malignancy. METHODS: This study was designed as a prospective, nonblinded, randomized, parallel clinical trial (Trial Number: MN Ostrava, 200604). With informed consent, patients undergoing gastrectomy for malignancy were randomized to J-pouch or Roux-en-Y reconstruction. The time taken for a test semisolid meal labeled with (99m)Tc-sulfur colloid to exit the reconstructed parts was measured by dynamic scintigraphy 1 year after resection. Quality of life was measured using the Eypasch questionnaire at the same time as functional emptying assessment. This trial was investigator-initiated. RESULTS: In all, 72 patients were included into the study. The time taken for the test meal to exit the postgastrectomy reconstruction was 16.5±10.0 minutes (mean ± standard deviation) in the Roux-en-Y group and 89.4±37.8 minutes in the "J-pouch" group; the difference was statistically significant (P<0.001). Emptying of the J-pouch appeared to be a linear decreasing function compared to the exponential pattern seen in the Roux-en-Y group. The quality of life measurement showed scores of 106±18.8 points (mean ± standard deviation) in the Roux-en-Y group compared to 122±22.5 points in the J-pouch group; the difference was statistically significant (P=0.0016). There were no important adverse events. CONCLUSION: After total gastrectomy, a J-pouch reconstruction empties more slowly and is associated with higher quality of life compared to Roux-en-Y reconstruction. Whether these two observations have a direct causative link remains unanswered.
Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic
Department of Nuclear Medicine University Hospital Ostrava Ostrava
Department of Surgery University Hospital Olomouc Olomouc
Department of Surgery University Hospital Ostrava
Department of Surgical Studies Faculty of Medicine University of Ostrava Ostrava
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17001249
- 003
- CZ-PrNML
- 005
- 20170206152817.0
- 007
- ta
- 008
- 170103s2017 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/OTT.S99628 $2 doi
- 035 __
- $a (PubMed)28031718
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Zonča, Pavel $u Department of Surgery, University Hospital Ostrava; Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava.
- 245 10
- $a J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial) / $c P. Zonča, T. Malý, P. Ihnát, M. Peteja, O. Kraft, K. Kuca,
- 520 9_
- $a PURPOSE: The aim of this study was to evaluate the quality of life and functional emptying of J-pouch versus Roux-en-Y reconstruction after total gastrectomy for malignancy. METHODS: This study was designed as a prospective, nonblinded, randomized, parallel clinical trial (Trial Number: MN Ostrava, 200604). With informed consent, patients undergoing gastrectomy for malignancy were randomized to J-pouch or Roux-en-Y reconstruction. The time taken for a test semisolid meal labeled with (99m)Tc-sulfur colloid to exit the reconstructed parts was measured by dynamic scintigraphy 1 year after resection. Quality of life was measured using the Eypasch questionnaire at the same time as functional emptying assessment. This trial was investigator-initiated. RESULTS: In all, 72 patients were included into the study. The time taken for the test meal to exit the postgastrectomy reconstruction was 16.5±10.0 minutes (mean ± standard deviation) in the Roux-en-Y group and 89.4±37.8 minutes in the "J-pouch" group; the difference was statistically significant (P<0.001). Emptying of the J-pouch appeared to be a linear decreasing function compared to the exponential pattern seen in the Roux-en-Y group. The quality of life measurement showed scores of 106±18.8 points (mean ± standard deviation) in the Roux-en-Y group compared to 122±22.5 points in the J-pouch group; the difference was statistically significant (P=0.0016). There were no important adverse events. CONCLUSION: After total gastrectomy, a J-pouch reconstruction empties more slowly and is associated with higher quality of life compared to Roux-en-Y reconstruction. Whether these two observations have a direct causative link remains unanswered.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Malý, Tomáš $u Department of Surgery, University Hospital Olomouc, Olomouc.
- 700 1_
- $a Ihnát, Peter $u Department of Surgery, University Hospital Ostrava; Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava.
- 700 1_
- $a Peteja, Matus $u Department of Surgery, University Hospital Ostrava; Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava.
- 700 1_
- $a Kraft, Otakar $u Department of Nuclear Medicine, University Hospital Ostrava, Ostrava.
- 700 1_
- $a Kuca, Kamil $u Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava; Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- 773 0_
- $w MED00165461 $t OncoTargets and therapy $g Roč. 10, č. - (2017), s. 13-19 $x 1178-6930
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28031718 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170206152950 $b ABA008
- 999 __
- $a ind $b bmc $g 1180389 $s 961816
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 10 $c - $d 13-19 $e 20161216 $m OncoTargets and therapy $n OncoTargets ther. $x MED00165461 $i 1178-6930
- LZP __
- $a Pubmed-20170103